Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
Katopodis, O., Souglakos, J., Stathopoulos, E., Christopoulou, A., Kontopodis, E., Kotsakis, A., Kalbakis, K., Kentepozidis, N., Polyzos, A., Hatzidaki, D., Georgoulias, V.Volume:
74
Language:
english
Journal:
Cancer Chemotherapy and Pharmacology
DOI:
10.1007/s00280-014-2509-6
Date:
August, 2014
File:
PDF, 440 KB
english, 2014